SCM
TMO icon

SeaStone Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

SeaStone Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-379,595
Closed -$35M – 45
2013
Q3 		$35M Buy
379,595
+66,718
+21% +$6.03M 4.42% 8
2013
Q2 		$26.5M Buy
+312,877
New +$26M 3.85% 11

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

SeaStone Capital Management's TMO Position: Q4 2013 in Review

SeaStone Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2013, closing a stake of 379,595 shares — an estimated $35M sold.

SeaStone Capital Management first reported a position in TMO in Q2 2013 and held it in 2 quarters. The position peaked at $35M in Q3 2013. 872 funds tracked by Wall St. Rank hold TMO as of Q4 2013.

  • SeaStone Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2013 after selling out during the quarter.
  • SeaStone Capital Management sold 379,595 Thermo Fisher Scientific shares in Q4 2013, an estimated $35M.
  • SeaStone Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 2 quarters.
  • SeaStone Capital Management's Thermo Fisher Scientific position peaked at $35M in Q3 2013.
  • 872 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2013.

Based on SeaStone Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.